Serum Concentrations of Folate Forms Following Supplementation of Multimicronutrients with 400 µg or 800 µg Mix of (6S)-5-Methyltetrahydrofolate and Folic Acid (1:1) in Women of Childbearing Age
- PMID: 39466653
- PMCID: PMC11605785
- DOI: 10.1002/mnfr.202400444
Serum Concentrations of Folate Forms Following Supplementation of Multimicronutrients with 400 µg or 800 µg Mix of (6S)-5-Methyltetrahydrofolate and Folic Acid (1:1) in Women of Childbearing Age
Abstract
Scope: A mixture of (6S)-5-methyltetrahydrofolate-calcium salt ((6S)-5-MTHF-Ca) and folic acid (FA) from multimicronutrient supplements may show a dose-dependent effect on serum folate concentrations.
Methods and results: The study compares fasting concentrations of serum folate spices after 8 weeks of either 400 or 800 µg day-1 of 1:1 folate mixture in 172 nonpregnant women. Serum (6S)-5-MTHF concentrations raise from a mean (SD) of 19.1 (13.4) to 73.9 (19.6) nmol L-1 in the 800 µg group and from 17.5 (9.4) to 54.5 (21.1) nmol L-1 in the 400 µg group (p < 0.001 within-group changes). The raise in serum (6S)-5-MTHF is stronger in the 800 µg compared to the 400 µg group (p < 0.001 between-group). The prevalence of FA concentrations ≥0.20 nmol L-1 increases between baseline and week 8 in both groups, but is not different between the groups (p = 0.116). The mean percentage of (6S)-5-MTHF of total serum folate increases in both intervention groups, but is not different between the groups at 8 weeks (95.5 (4.1)% versus 94.4 (5.7)%, p = 0.309).
Conclusions: Supplementation of multimicronutrients with 800 µg folate mix for 8 weeks causes higher serum (6S)-5-MTHF concentrations, but not a higher prevalence of detectable FA compares to 400 µg folate.
Keywords: folic acid; methylfolate; pregnancy; serum folate; supplements.
© 2024 The Author(s). Molecular Nutrition & Food Research published by Wiley‐VCH GmbH.
Conflict of interest statement
R.O. received speaker honorary and research grants for other research projects from P&G Health Germany. C.S. is employed by BioTeSys GmbH, Esslingen. E.R. and J.G. have no conflict of interests to declare.
References
-
- Czeizel A. E., Dudas I., New Engl. J. Med. 1992, 327, 1832. - PubMed
-
- Bibbins‐Domingo K., Grossman D. C., Curry S. J., Davidson K. W., Epling J. W. Jr, García F. A., Kemper A. R., Krist A. H., Kurth A. E., Landefeld C. S., Mangione C. M., Phillips W. R., Phipps M. G., Pignone M. P., Silverstein M., Tseng C. W., J. Am. Med. Assoc. 2017, 317, 183.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical